Daniel C Malone

发表

Testing the face validity and inter-rater agreement of a simple approach to drug-drug interaction evidence assessment

Harry Hochheiser, Richard D Boyce, Amy J Grizzle, 2020, J. Biomed. Informatics.

Integrating the Practical Robust Implementation and Sustainability Model With Best Practices in Clinical Decision Support Design: Implementation Science Approach

Chen-Tan Lin, Michael G Kahn, Russell E Glasgow, 2020, Journal of medical Internet research.

Applying Clinical Decision Support Design Best Practices With the Practical Robust Implementation and Sustainability Model Versus Reliance on Commercially Available Clinical Decision Support Tools: Randomized Controlled Trial

Chen-Tan Lin, Michael G Kahn, David P Kao, 2021, JMIR medical informatics.

Critical issues associated with drug-drug interactions: highlights of a multistakeholder conference.

Amy J Grizzle, Lisa E Hines, Daniel C Malone, 2011, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Drug-drug interaction software quality assurance: Lessons learned.

Lisa E Hines, Daniel C Malone, Terri L Warholak, 2011, Journal of the American Pharmacists Association : JAPhA.

Performance of Drug–Drug Interaction Software for Personal Digital Assistants

Daniel C Malone, John E. Murphy, D. Malone, 2006, The Annals of pharmacotherapy.

Identifying Common Methods Used by Drug Interaction Experts for Finding Evidence About Potential Drug-Drug Interactions: Web-Based Survey

Jodi Schneider, John Horn, Carol Collins, 2019, Journal of medical Internet research.

International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.

Michael Koller, Corneel Coens, Andrew Bottomley, 2020, The Lancet. Oncology.

Concordance of severity ratings provided in four drug interaction compendia.

Amy J Grizzle, Daniel C Malone, Jacob Abarca, 2004, Journal of the American Pharmacists Association : JAPhA.

The Good, the Bad, and the Different: A Primer on Aspects of Heterogeneity of Treatment Effects

Lisa E Hines, Daniel C Malone, D. Malone, 2014, Journal of managed care & specialty pharmacy.

Incidence of Exposure of Patients in the United States to Multiple Drugs for Which Pharmacogenomic Guidelines Are Available

Matthias Samwald, Kathrin Blagec, Hong Xu, 2016, PloS one.

The Role of Pharmacoeconmic Modeling

Daniel C Malone, D. Malone, 2005, Journal of managed care pharmacy : JMCP.

Health services use and health care costs of obese and nonobese individuals.

Marsha A Raebel, Daniel C Malone, Stanley Xu, 2004, Archives of internal medicine.

Prescribers’ Knowledge of and Sources of Information for Potential Drug-Drug Interactions

Daniel C Malone, Raymond L Woosley, Jacob Abarca, 2008, Drug safety.

Development of computerized alerts with management strategies for 25 serious drug-drug interactions.

Amy J Grizzle, Daniel C Malone, John E. Murphy, 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Recommendations for selecting drug-drug interactions for clinical decision support.

Shiew-Mei Huang, John Poikonen, David W Bates, 2016, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Measurement of Adherence in Pharmacy Administrative Databases: A Proposal for Standard Definitions and Preferred Measures

Marsha A Raebel, Daniel C Malone, D. Malone, 2006, The Annals of pharmacotherapy.

Evaluation of the Performance of Drug-Drug Interaction Screening Software in Community and Hospital Pharmacies

Daniel C Malone, Jacob Abarca, John E. Murphy, 2006, Journal of managed care pharmacy : JMCP.

International Society for Pharmacoeconomics and Outcomes Research Comments on the American Society of Clinical Oncology Value Framework.

Karl Claxton, Milton C Weinstein, Maarten J. IJzerman, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Community pharmacy managers' perception of computerized drug-drug interaction alerts.

Amy J Grizzle, Daniel C Malone, Raymond L Woosley, 2006, Journal of the American Pharmacists Association : JAPhA.

Pharmacist Workload and Pharmacy Characteristics Associated With the Dispensing of Potentially Clinically Important Drug-Drug Interactions

Amy J Grizzle, Daniel C Malone, Raymond L Woosley, 2007, Medical care.

Evaluation of warfarin drug interaction listings in US product information for warfarin and interacting drugs.

Klaus Romero, Lisa E Hines, Daniel C Malone, 2011, Clinical therapeutics.

Using indirect comparisons in pharmacoeconomic studies--time for implementation.

Daniel C Malone, D. Malone, 2007, Clinical therapeutics.

Assessing patients' information needs regarding drug-drug interactions.

Lisa E Hines, Daniel C Malone, D. Malone, 2013, Journal of the American Pharmacists Association : JAPhA.

Assessment tool for pharmacy drug-drug interaction software.

Amy J Grizzle, Lisa E Hines, Daniel C Malone, 2011, Journal of the American Pharmacists Association : JAPhA.

Recommendations for Generating, Evaluating, and Implementing Drug‐Drug Interaction Evidence

Lisa E Hines, Daniel C Malone, John E. Murphy, 2012, Pharmacotherapy.

Pharmacists' awareness of clinical decision support in pharmacy information systems: an exploratory evaluation.

Amy J Grizzle, Lisa E Hines, Daniel C Malone, 2011, Research in social & administrative pharmacy : RSAP.